Abstract
It is well established (Gregoriadis, 1981) that following intravenous injection, liposomes and entrapped drugs are sooner or later taken up by the reticuloendothelial system (RES). Rate of uptake in particular tissues of the RES depends on vesicle size, surface charge and lipid composition, amount of liposomal lipid given, animal species and physiological state. For instance, a large vesicle size and/or a negative surface charge promote rapid uptake by tissues. Further, depending on the lipid composition of injected liposomes, plasma high density lipoproteins (HDL) will remove phospholipid molecules, destabilize vesicle structure and lead to entrapped drug release into the circulation. Thus, tissues will take up vesicles in various stages of destabilization and with a portion of their drug contents lost.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Allen, T.M., 1981, A study of phospholipid interaction between high density lipoprotein and small unilamellar vesicles, Biochim. Biophys. Acta, 640:385.
Ashwell, G. and Moreli, A.G., 1976, The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins, Adv. Enzymol, 41:99.
Gregoriadis, G., 1974, Structural requirements for the specific uptake of macromolecules and liposomes by target tissues, in: “Enzyme Therapy in Lysosomal Storage Diseases”, J.M. Tager, G.J.M. Hooghwinkel and W.Th. Daems, eds., North-Holland Publishing Co., Amsterdam.
Gregoriadis, G., 1981, Targeting of drugs: Implications in medicine, The Lancet, 2:241.
Gregoriadis, G., 1983, Targeting of drugs with molecules, cells and liposomes, TIPS, 4:304
Gregoriadis, G., ed., 1984, “Liposome-Technology”, vols. I–III, CRC Press Inc., Boca Raton.
Gregoriadis, G. and Davis, C., 1979, Stability of liposomes in-vivo and in-vitro is promoted by their cholesterol content and the presence of blood cells, Biochem. Biophys. Res. Comm., 89:1287.
Gregoriadis, G. and Meehan, A., 1981, Interaction of antibody-bearing small unilamellar liposomes with antigen-coated cells: the effect of antibody and antigen concentration on the liposomal and cell surface respectively, Biochem. J., 200:211.
Gregoriadis, G. and Neerunjun, D., 1975 Homing of liposomes to target cells, Bioche Biophys. Res. Comm., 65:537.
Gregoriadis, G. and Senior, J., 1980, The phospholipid component of small unilamellar liposomes controls the rate of clearance of entrapped solutes from the circulation, FEBS Lett., 119:43.
Gregoriadis, G. and Senior, J., 1984, Targeting of small unilamellar liposomes to the galactose receptor in-vivo, Biochem. Soc. Trans., 12:337.
Gregoriadis, G., Neerunjun, D.E. and Hunt, R., 1977, Fate of a liposome-associated agent injected into normal and tumour-bearing rodents. Attempts to improve localization in tumour tissues, Life Sci., 21:357.
Gregoriadis, G., Mah, M.M. and Meehan, A., 1981, Interaction of antibody-bearing small unilamellar liposomes with target free antigen in-vitro and in-vivo: Some influencing factors, Biochem. J., 200:203.
Hashimoto, Y., Sugawara, M., Masuko, T. and Hojo, H., 1983, Anti-tumour effect of actinomycin D entrapped in liposomes bearing subunits of tumour-specific monoclonal immunoglobulin M antibody, Cancer Res., 43:5328.
Heath, T.D., Fraley, R.T. and Papahadjopoulos, D., 1980, Antibody targeting of liposomes: Specific interaction of vesicles conjugated to anti-erythrocyte F(ab’)2, Science, 210:539.
Hwang, K.J., Luk, K-F.S. and Beaumier, P.L., 1980, Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: A kinetic study, Proc. Natl. Acad. Sci. USA, 77:4030.
Kirby, C. and Gregoriadis, G., 1980, The effect of the cholesterol content of small unilamellar liposomes on the fate of their lipid components in-vivo, Life Sci., 27:2223.
Kirby, C. and Gregoriadis, G., 1981, Plasma-induced release of solutes from small unilamellar liposomes is associated with pore formation in the bilayers, Biochem. J., 199:251.
Kirby, C. and Gregoriadis, G., 1983, The effect of lipid composition of small unilamellar liposomes containing melphalan and vincristine on drug clearance after injection into mice, Biochem. Pharmacol., 32:609.
Kirby, C. and Gregoriadis, G., 1984a, A simple novel method for efficient drug entrapment in liposomes, in: “Liposome Technology”, Vol. I, G. Gregoriadis, ed., CRC Press Inc., Boca Raton.
Kirby, C. and Gregoriadis, G., 1984b, Incorporation of Factor VIII into liposomes, in: “Liposome Technology”, Vol. II, G. Gregoriadis, ed., CRC Press Inc., Boca Raton.
Kirby, C. and Gregoriadis, G., 1984c, Preparation of liposomes containing Factor VIII for oral treatment of haemophilia, J. Microencap., 1:33.
Kirby, C., Clarke, J. and Gregoriadis, G., 1980, Cholesterol content of small unilamellar liposomes controls phospholipid loss to high density lipoproteins in the presence of serum, FEBS Lett., 111:324.
Kirby, C., Clarke, J. and Gregoriadis, G., 1980, Effect of the cholesterol content of small unilamellar liposomes on their stability in-vivo and in-vitro, Biochem. J., 186:591.
Krupp, L., Chobanian, A.V. and Brecher, I.P., 1976, The in-vivo transformation of phospholipid vesicles to a particle resembling HDL in the rat, Biochem. Biophys. Res. Commun., 72:1251.
Martin, F.J. and Papahadjopoulos, D., 1982, Irreversible coupling of immunoglobulin fragments to preformed vesicles, J. Biol. Chem., 257:286.
Mayhew, E. and Rustum, Y., 1983, Effect of liposome-entrapped chemo-therapeutic agents on mouse primary and metastatic tumours, Biol. Cell., 47:81.
Moreli, A.G., Gregoriadis, G., Scheinberg, I.H., Hickman, J. and Ashwell, G., 1974, The role of sialic acid in determining the survival of glycoproteins in the circulation, J. Biol. Chem., 246:1461.
van Oss, C.J., Gillman, CF., Bronson, P.M. and Border, J.JR., 1974, Phagocytosis-inhibiting properties of human serum alpha-1 acid glycoprotein, Immunol. Comm., 3:321.
Patel, H.M., Tüzel, N.S. and Ryman, B.E., 1984, Inhibitory effect of cholesterol on the uptake of liposomes by liver and spleen, Biochim. Biophys. Acta, 761:142.
Poste, G., 1983, Liposomes targeting in-vivo: Problems and opportunities, Biol. Cell., 47:19.
Proffitt, R.T., Williams, L.E., Presant, C.A., Tin, G.W., Uliana, J.A., Gamble, R.C and Baldeschwielar, J.D., 1983, Liposomal blockade of the reticuloendothelial systems: Improved tumour imaging with small unilamellar vesicles, Science, 220:502.
Scherphof, G., Roerdink, F., Waite, M. and Parks, I., 1978, Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high density lipoproteins, Biochim. Biophys. Acta, 542:296.
Scherphof, G., Damen, J. and Wilschut, J., 1984, Interactions of liposomes with plasma proteins, in: “Liposome Technology”, G. Gregoriadis, ed., CRC Press Inc., Boca Raton.
Senior, J. and Gregoriadis, G., 1982a, Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components, Life Sci., 30:2123.
Senior, J. and Gregoriadis, G., 1982b, Is half-life of circulating small unilamellar liposomes determined by changes in their permeability?, FEBS Lett., 145:109.
Senior, J. and Gregoriadis, G., 1984, Methodology in assessing liposomal stability in the presence of blood, clearance from the circulation of injected animals, and uptake by tissues, in: “Liposome Technology”, Vol. III, G. Gregoriadis, ed., CRC Press Inc., Boca Raton.
Senior, J., Gregoriadis, G. and Mitropoulos, K., 1983, Stability and clearance of small unilamellar liposomes: Studies with normal and lipoprotein-deficient mice, Biochim. Biophys. Acta, 760:111.
Spanjer, H.H. and Scherphof, G., 1983, Targeting of lactosylceramide-containing liposomes to hepatocytes in-vivo, Biochim. Biophys. Acta, 734:40.
Szoka, F. and Mayhew, E., 1983, Alteration of liposome disposition in-vivo by bilayer situated carbohydrates, Biochem. Biophys. Res. Commun., 110:140.
Teradaira, R., Kolb-Bachofen, V., Schlepper-Schafer, J. and Kolb, H., 1983, Galactose-particle receptor on liver macrophages. Quantitation of particle uptake, Biochim. Biophys. Acta, 759:306.
Toonen, P.A.H.M. and Crommelin, D.J.A., 1983, Immunoglobulins as targeting agents for liposome-encapsulated drugs, Pharm. Weekblad Scientific Edition, 5:269.
Tümer, A., Kirby, C., Senior, J. and Gregoriadis, G., 1983, Fate of cholesterol-rich unilamellar liposomes containing 111In-labelled bleomycin after subcutaneous injection into rats, Biochim. Biophys. Acta, 760:119.
Tyrrell, D.A. and Ryman, B.E., 1980, Liposomes: Bags of potential, Essays Biochem., 16:49.
Wolff, B. and Gregoriadis, G., 1984, The use of monoclonal anti-Thy1, IgG1 for the targeting of liposomes to AKR-A cells in-vitro and in-vivo, Submitted.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Gregoriadis, G., Senior, J., Wolff, B., Kirby, C. (1984). Fate of Liposomes In Vivo: Control Leading to Targeting. In: Gregoriadis, G., Poste, G., Senior, J., Trouet, A. (eds) Receptor-Mediated Targeting of Drugs. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4862-7_14
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4862-7_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4864-1
Online ISBN: 978-1-4684-4862-7
eBook Packages: Springer Book Archive